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 Abstract 
 
The authors describe an amperometric biosensor for the amino acid L-arginine (L-Arg). It 
is based on the use of a Nafion/Polyaniline (PANi) composite on a platinum screen-printed 
electrode (Pt-SPE) using a novel recombinant arginine deiminase isolated from Mycoplasma 
hominis. The protein was over-expressed, purified and employed as a biorecognition element of 
the sensor. Enzymatic hydrolysis of L-Arg leads to the formation of ammonium ions which diffuse 
into the Nafion/PANi layer and induce the electroreduction of PANi at a potential of -0.35 V (vs 
Ag/AgCl). L-Arg sensitivity was 684±32 A⋅M-1⋅m-2, and the apparent Michaelis-Menten constant 
(KMapp) 0.31±0.05 mM. The calibration plot was linear over the range 3 - 200 µM L-Arg, the limit 
of detection was 1 μM, and the response time (for 90% of the total signal change to occur) 15 s. 
The sensor was selective and exhibited good storage stability (> 1 month without loss in signal). 
The biosensor was applied to the analysis of L-Arg in pharmaceutical samples and of ammonium 
and L-Arg in spiked human plasma obtained from blood of healthy volunteers and those with a 
hepatic disorder. Data generated was found to be in good agreement with a reference fluorometric 
enzymatic assay. 
Keywords: L-Arginine, ammonium ions, amperometry, nafion, polyaniline, recombinant 
enzyme, plazma samples, pharmaceuticals 
  
1. Introduction 
 
L-Arginine is one of 20 amino acids found in proteins which play an important role in 
cellular metabolism. Its guanidine group contains five potential hydrogen bond donors that are 
positioned for favourable interactions with biological hydrogen bond acceptors [1]. It is 
dispensable in healthy individuals as it may be formed from other amino acids. However, in people, 
who are seriously ill or injured, higher quantities of L-Arginine are required, as the body may be 
unable to synthesise it in sufficient quantities [2]. Certain cancers may be auxotrophic for a 
particular amino acid, and amino acid deprivation is one approach used to treat these tumours. It 
has been suggested that arginine-degrading enzymes may be effective in the control of arginine-
dependent cancers [3]. Therefore, it is important to provide a means of monitoring levels of this 
amino acid in biological liquids [4], nutrition supplements and most recently, cosmetics, due to 
the widespread use of this molecule. 
A variety of detection procedures for L-Arginine analysis have been developed, most of 
which involve time-consuming, costly and complex techniques, such as high-performance liquid 
chromatography [5]. Other examples are methods based on spectrophotometry [6], fluorometry 
[7], atomic absorption spectrometry [8], catalytic–thermometric titrametry [9], capillary 
electrophoresis [10], and enzymatic assays [11, 12]. 
There is an ongoing demand for easy-to-use, cost effective and decentralised diagnostic 
tools for clinical practice. The construction of L-Arginine biosensors has already been reported 
and many of these are based on the use of bacterial cells [13] and enzymes [14] within a recognition 
layer. Earlier reports on enzyme-based L-Arginine sensors employed L-Arg oxidase co-
immobilised with horseradish peroxidase on a screen-printed amperometric electrode [14, 15]. 
Others were based on co-immobilised arginase and urease on the surface of pH-electrode, 
ammonium-selective (ASE) electrodes and thin-film interdigitated conductometric electrode [16-
20]. Most of these biosensors exhibited good selectivity and were responsive to the target analyte, 
though characterised by poor precision/insufficient stability and low sensitivity.  
Non-enzymatic approaches include the use of electrocatalytic materials e.g. Martinez-
Perinan et al. [21] reported the electrochemical detection of L-Arginine, L-ornithine and L-
citrulline in urine and serum, based on the use of Ni(OH)2 nanoparticle-modified carbon nanotubes 
as a HPLC electrochemical detector. However, this method was useful only for detection of a 
group of amino acids and was not found to be selective for L-Arginine. 
Stasyuk et al. [22a] proposed a novel L-Arg-selective amperometric bi-enzyme sensor, 
based on recombinant human arginase I, commercial urease and Nafion/Polyaniline (PANi) 
modified platinum electrodes, with sensitivity of 110 A⋅M-1⋅m-2 and wide linear range 0.07 – 0.6 
mM. However, the main drawback of this biosensor was the insufficient working and storage 
stability. When multiple reactions take place in the same biolayer, there are limitations in relation 
to the rate of reaction and stability [23]. 
L-Arginine can be degraded by several enzymes including arginine deiminase (ADI), 
which is now commercially available, but the price of highly purified enzyme is prohibitive. ADI 
has high affinity for arginine and catalyses the irreversible hydrolysis of arginine to citrulline and 
ammonia. ADI belongs to a newly classified superfamily of guanidine-group-modifying enzymes 
[24]. ADI has been successfully utilised for fluorometric detection of L-Arg in beverages [12]. 
ADI extracted from Pseudomonas putida MTCC 1313 was employed as a recognition element for 
ASE-based sensor for detection in juices [25]. However, some inconsistencies in the analytical 
performance were reported. 
Herein we report the construction of an original, sensitive, selective and stable 
amperometric biosensor for L-arginine determination. In order to realise this an ammonium-
sensing PANi layer was electropolymerised via potential cycling on a Nafion-modified 
commercial platinum screen-printed electrode (Pt-SPE) as described previously [22a, 26]. 
Subsequently, a novel recombinant arginine deiminase (ADI) from Mycoplasma hominis was 
deposited on the PANi/Nafion/Pt-SPE surface and a biorecognition membrane formed by cross-
linking in saturated glutaraldehyde (GA) vapour (see scheme Fig. 1S). The L-Arg biosensor was 
employed in quantitation studies of both pharmaceutical (food supplement) and plasma samples 
from 15 human volunteers. 
 
2. Material and methods 
 
2.1. Reagents 
 
Arginine deiminase (EC 3.5.3.6) from Mycoplasma hominis with an activity of 30-35 
U⋅mg-1 (KM = 0.35 mM) [27] was over-expressed and purified in our laboratory [27]. Hydrochloric 
acid, sodium chloride, NaH2PO4, Na2HPO4, 5% Nafion® perfluorinated resin solution, 
glutaraldehyde (GA) (50% w/v aqueous solution), ethanol, bovine serum albumin (fraction V, 
96%), and γ-aminobutyric acid (GABA) were purchased from Sigma-Aldrich (Germany, 
www.sigmaaldrich.com). Aniline (99%) was purchased from Sigma-Aldrich (Germany) and 
redistilled before use (Important: only freshly prepared aniline should be used for 
electropolymerisation studies). L-Arginine monohydrochloride was purchased from Sigma 
Aldrich (Japan, www.sigmaaldrich.com), ammonium chloride and L-lysine were obtained from 
Fluka (Germany, www.sigmaaldrich.com). All the chemicals and solvents used were of analytical-
reagent grade and used without further purification. L-Arg containing pharmaceutical 
“Aminoplazmal 10% E” was purchased from Mr Braun Melsungen AG (Germany, 
www.bbraun.de).  
20 mM phosphate buffer containing 20 mM sodium chloride (further referred to as PB) pH 
7.4, was used as the supporting electrolyte during electrochemical measurements. All solutions 
were prepared using 18.2 MΩ⋅cm purified water produced using a Simplicity water purification 
system (Millipore, France). All glassware and polyethylene materials were rinsed with ultrapure 
water and dried before use. 
 
2.2. Instrumentation 
 
All biosensors employed a three-electrode screen-printed platform (DRP-C550, DropSens, 
Spain) with a platinum working electrode (4 mm diameter), a platinum counter and a Ag/AgCl 
reference electrode. Amperometric measurements were performed using a portable potentiostat 
(µStat 400, DropSens, Spain), controlled by DropView 2.0 software and used in accordance with 
the producer’s guide. Amperometric detection was performed at -0.35 V vs. the Ag/AgCl reference 
electrode at room temperature in an open 3 mL vessel filled with 20 mM PB, pH 7.4 under vigorous 
stirring. Prior to use, the biosensors were soaked in PB for 30 min at room temperature and the 
sensor response to a particular substrate concentration was taken as an average of three 
measurements. The long-term stability of the biosensor was evaluated via repeated determination 
of the biosensor response every 3-4 days. In between testing the devices were stored in PB at 4 °C. 
 
2.3. Arginine deiminase over-expression and purification 
 
ADI expression, renaturation and purification were performed as reported previously with 
some modifications [27]. Cells of Escherichia coli BL21 (DE3) fhuA2 [lon] ompT gal (λ sBamHIo 
∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5) [dcm] ∆hsdS [28] were transformed with 
plasmid pET3d-ADI. Transformants were selected on Luria-Bertani medium at 37 °C 
supplemented with 18 g⋅L⁻¹ of agar, 100 mg⋅L⁻¹ of ampicillin, 0.2% of arginine and 0.5% of 
glucose. Selected transformants were employed to produce ADI using C-750501 medium 
supplemented with 1.25% glycerol and 0.01% lactose following autoinduction protocol modified 
earlier [27].   
The induced cells were harvested by centrifugation (5000 × g for 15 min at 4 ºC), washed 
with 20 mM sodium phosphate buffer, pH 7.2, and stored at -70 ºC.  To obtain a suspension of 
ADI inclusion bodies the bacterial pellet was resuspended in 50 mM Tris-HCl buffer, pH 7.8 
containing 1 mM EDTA and 0.2% lysozyme and treated as described earlier. The pellet containing 
ADI synthesised as inclusion bodies was washed with 20 mM sodium phosphate pH 7.2, 1 mM 
EDTA, 4% Triton X-100, re-pelleted and used for renaturation and purification of the enzyme as 
optimised previously [27].  
The solution of purified enzyme was concentrated using an ultrafiltration spin column 
(Vivaspin-Turbo 15, Sartorius Stedim Biotech GmbH, Germany), filter-sterilised using 0.22 µM 
filters (CE 0459 Millex-gv, Millipore, USA) and stored at 4 ºC. Protein concentration was 
determined by the Lowry method. ADI activity was determined as described previously [29]. One 
unit (U) of activity was defined as the amount of enzyme that converted 1 µmol L-arginine to L-
citrulline and ammonium per min at 37 ºC.  
 
2.4. Electrode modification with PANi-Nafion composite 
 
An aliquot (2 µL) of 2 wt % Nafion solution (prepared from 5% sample by 96% ethanol 
dilution) was deposited onto the surface of a Pt-SPE and air-dried for 15 min. The aniline 
polymerisation was performed using cyclic voltammetry in 0.2 M aniline solution in 0.5 M HCl 
by sweeping the potential between -0.4 V and 1.0 V (vs. Ag/AgCl) at a scan rate of 0.02 V⋅s-1 at 
room temperature for 7 cycles. The PANi/Nafion/Pt-SPE was rinsed thoroughly with distilled 
water and then dried in air for 15 min. All treatments and measurements were carried out at room 
temperature. 
 
2.5. Enzyme immobilisation procedure 
 
In order to prepare the L-Arg-selective membrane 18 mL of ADI solution (300 U⋅mL⁻¹ in 
1 M NaCl and 20 mM PB, pH 7.2) were mixed with 2 µL of 50% BSA in 20 mM PB, pH 7.2. 2 
µL of this ADI-BSA solution was drop-cast onto the PANi/Nafion/Pt-SPE surface and incubated 
in saturated GA (25% w/v) vapour for the cross-linking for 35 min in an exhaust fume hood at 
room temperature. Prior to use, the bioelectrodes were dried for 1 h at 4 ºC, following which they 
were washed 3 times with 0.02 M PB, pH 7.4 to remove residual GA. The electrodes with bio-
selective membranes were stored in 50 mM PB, pH 7.4 at 4 ºC until use (Fig. 1S). 
 
2.6. Preparation of real samples and standard addition assay 
 
Plasma samples from human volunteers were obtained from the Feofaniya Clinical hospital 
(Kyiv, Ukraine) following the guidelines of the European Group on Ethics in Science and New 
Technologies of the European Commission (#17, 4.02.2003) and the statement by the Ethics 
Committee of the American Psychological Association. Ukrainian Government personal data 
protection rules as well as the Ethics Committee of the Institute of Molecular Biology and Genetics 
NAS of Ukraine rules (approved on 25.04.2012 to conduct the relevant research in the frame of 
SMARTCANCERSENS Project, PIRSES-GA-2012-318053) were followed. This procedure was 
adhered to during collection, delivery and investigation of all human biological samples. 
Venous blood (2 µL) was collected in a heparinised cold tube. The tube was centrifuged at 
1500 g for 10 min and cell-free supernatant removed. All plasma samples were kept cold in an ice 
box during the time between collection and biosensor measurement. L-Arg assay in the test 
samples was performed by means of amperometry at -0.35 V vs. Ag/AgCl using the standard 
addition method. An aliquot of the plasma sample was directly injected into the measuring vessel 
in order to obtain a 10-fold dilution. L-Arg concentration in human plasma samples were analysed 
by the DMO-based fluorometric enzymatic assay reported previously [11], and used as a reference 
methodology.  
  
3. Results and Discussion 
 
3.1. Modification of platinum screen printed electrodes with Nafion/PANi  
 
Prior to PANi deposition via electropolymerisation, the Pt-SPE working electrode surface 
was modified with Nafion (2% in EtOH), sulphonated tetrafluoroethylene polymer. The acidic 
groups on the surface of the polymer acted as charge compensator in the course of anodic 
polymerisation of aniline [30]. Following the drying step at room temperature, the 
electropolymerisation of aniline took place as per procedure 2.4 (see Fig. 2S for growth cycles), 
following optimisation of potential limits, scan rate and cycle number.  
The profiles of cyclic voltammograms carried out during the electrodeposition of PANi 
onto Nafion/Pt-SPE differed slightly with respect to those reported in the literature [22]. The 
difference results in a ca. 0.15 V cathodic shift for the arising peaks taking into consideration the 
screen-printed reference electrode. The anodic scan of the first cycle was characterised by a large 
peak of monomer oxidation at 0.9 V. The backward scan was characterised by a nucleation loop, 
probably due to the new phase formation, followed by a broad cathodic wave. Upon further 
cycling, the monomer oxidation peak decreased with simultaneous growth of two redox processes 
at 0 – 0.15 V (emeraldine) and 0.5 – 0.65 V (pernigraniline), confirming the typical redox 
characteristics of polyaniline films which were additionally indicated visually by the colour change 
to dark green of the ermeraldine (half oxidised form).  
 
3.2. Electrochemical properties of Nafion/PANi-modified electrode towards ammonium 
ions 
 
The electrochemical properties of Nafion/PANi-modified electrode were examined using 
cyclic voltammetry at pH 7.4 (Fig. 1A). The addition of NH4Cl to the solution led to the 
appearance of a voltammetric response in the form of increased cathodic currents (-0.2 to -0.4 V). 
 
Figure 1. Amperometric ammonium detection on 
Pt-SPE modified with Nafion/PANi composite. A: Cyclic 
voltammograms recorded before and after addition of 
NH4Cl (PB pH 7.4, scan rate 20 mV⋅s-1); B: an example 
of amperometric response of transducer to successive 
additions of NH4Cl (-0.35 V, PB pH 7.4); C: calibration 
curve for ammonium detection obtained at 
PANi/Nafion/Pt-SPE (n=3). 
 
Ammonium ions which diffused to the 
Nafion/PANi layer provoked the reduction of PANi 
on Pt-SPE to the leucoemeraldine form. If the 
PANi/Nafion composite is polarised at a reduction 
potential, the cathodic response is proportional to the 
ammonium ion concentration in the solution [31].  
In order to determine the optimal polarisation 
voltage for amperometric detection, ammonium ion 
assays at a range of applied potentials (-0.2 to -0.4 V) 
were carried out with the current maximum found at 
-0.35 V (Fig. 3S). Hydrodynamic data for the 
PANi/Nafion/Pt-SPE is shown in (Fig. 1B), and 
exhibited a consistent increase in the steady state 
cathodic current in response to increased ammonium 
ion concentration. Under the same conditions, 
PANi/Nafion/Pt-SPE was completely insensitive to 
L-Arg (Fig. 2B). The resultant calibration curve 
exhibited a linear range from 0.003 to 0.2 mM and a 
sensitivity value within the linear range of 701±33 
A⋅M-1⋅m-2 (Fig. 1C). The limit of detection (LOD) 
calculated as 3×SD was 1 µM NH4Cl.  
 3.3. Immobilisation of ADI and biosensor performance in model media (PB pH 7.4) 
 
ADI was immobilised on PANi/Nafion/Pt-SPE by cross-linking with BSA in saturated GA 
vapour according to experimental section 2.5. The presence of BSA ensured a high operational 
stability due to ideal conditions for retaining the maximal enzyme activity. 
The pH optimum resulting in highest activity for the sensor was 7.2 in 20 mM PB (Fig. 
4S), which is compatible with the requirements for physiological testing. These conditions were 
employed for further L-Arg assays. Voltammetric studies of ADI/PANi/Nafion/Pt-SPE are shown 
in Fig. 2A. The addition of L-Arg into the cell resulted in a significant increase in the cathodic 
current at potentials between -0.2 and -0.4 V (vs. Ag/AgCl).  
The CV results and previous ammonium ion detection data indicated that -0.35 V was a 
suitable applied potential for the detection of L-Arg. In Fig. 2B, the amperometric responses of the 
L-Arg biosensor are reported showing a consistent increase in the cathodic current as a result of 
increasing L-Arg concentration. The calibration curve is shown in Fig. 2C. The dynamic range 
was linear between 0.003 and 0.2 mM L-Arg (Fig 2D). The KMapp derived from the Lineweaver-
Burk plot was 0.31±0.05 mM for L-Arg. This value is practically the same as that for ADI in 
solution (0.35 mM [27]). The sensitivity was calculated as 684±32 A⋅M-1⋅m-2, LOD was 1 µM and 
the response time was 15 s. 
 
    
   
Figure 2. Amperometric L-Arg detection on a ADI/PANi/Nafion/Pt-SPE. A: Cyclic voltammograms 
recorded before and after addition of 0.5 mM L-Arg (blue and red curves, respectively; PB pH 7.4, scan 
rate 20 mV⋅s-1); B: an example of amperometric response of PANi/Nafion/Pt-SPE (1) and L-Arg biosensor 
(2) to successive additions of L-Arg (-0.35 V, PB pH 7.4); C: calibration curve for L-Arg detection at 
ADI/PANi/Nafion/Pt-SPE (n=3); D) Lineweaver-Burk plot for calibration curve.  
 
The efficacy of the ADI reaction was calculated from the Isteady-state/2 values, presented in 
the graphs in Fig. 1C and Fig. 2C. The similarity of the calibration curves for detection of both 
ammonium ions and L-Arg indicates that the conversion rate of L-Arg to citrulline and ammonium 
ion was 97.6%. In addition, the almost ideal L-Arg conversion rate means that the procedure 
chosen for ADI immobilisation on the Nafion/PANi/Pt-SPE was the most enzyme-friendly one 
(i.e. the active sites, conformation and catalytic activity of the ADI were not altered significantly 
during the immobilisation procedure). 
The stability of ADI/PANi/Nafion/Pt-SPE was explored by monitoring its response to the 
injection of a 0.2 mM L-Arg standard solution over a period of 35 days. The biosensor preserved 
around 93% (SD = 6.5%) stability after 35 days storage or following 100 assays (Fig. 6S). 
The comparison of the analytical performance of the L-Arg-selective biosensor with the 
analytical parameters of systems described in the literature (Table 1) shows that the biosensor 
realised here has advantageous characteristics, yielding one of the lowest limits of detection 
together with high sensitivity, wide linear range and long-term stability, thus making it 
potentially suitable for clinical sample analysis for the L-Arg levels of humans (60-100 µM in 
blood [32]). 
The effects of some possible interfering amino acids (Ile, Lys, Thr, Orn, Ser, Val, Cys, 
GABA and citrulline) on the PANi/Nafion/Pt-SPE composite were investigated and the presence 
of amino acids in PB showed negligible response (significance level less than 5%) (Fig. 5S). 
It was reported earlier, that canavanine, the substrate of arginase I, is hydrolysed by ADI 
and induces an analytical signal [33]. However, an impact of canavanine on the L-Arg assay is not 
important due to the rare presence of this compound in biological fluids (blood, serum/plasma and 
urine).  
Notably, an addition of highly concentrated solutions of chloride salts (over 50 mM, Fig. 
7S) causes a decrease in the current due to a potential shift at the internal open Ag reference 
electrode of the biosensor, which coincides well with the results obtained by Strehlitz et al. [31].  
 
3.4. L-Arg assay in pharmaceutical and human plasma samples  
 
In order to demonstrate feasibility of the L-Arg biosensor for the assessment of target 
analyte concentrations in real samples, some L-Arg-containing pharmaceutical and human plasma 
samples were collected and analysed. The results were compared with the L-Arg content estimated 
by the reference method (DMO-based fluorometric enzymatic method [11] (Table 2).  
L-Arg assay in commercial pharmaceutical samples was performed by amperometric 
detection using a portable potentiostat (µStat 400), following the standard addition method (Fig. 
3). 
 
Table 1: Analytical characteristics of reported L-Arg biosensors. 
Mode of signal 
registration Biocomponent LOD, mM 
Linear 
range, mM 
Response 
time (95%), 
min 
Stability, 
days Reference 
Potentiometric, 
ASE* Bacterial cells  0.05 – 1.0   [13] 
Potentiometric, 
NH3 gas sensor U/A**  0.03 – 3.0 5.0  [18] 
Potentiometric, 
ASE U/A 0.01 0.1 – 30 1.5 – 4.0 21 [16] 
Potentiometric, 
pH U/A  0.025 – 0.31 10  [17] 
Potentiometric, 
ASE U/A 0.1 0.12 – 40 1.5 – 5.0 15 [19] 
Conductometric U/A 0.0005 0.01 – 4.0 2.0 45 [20] 
Amperometric U/A 0.038 0.07 – 0.6 0.17 3 [22a] 
Amperometric Urease/Yeast cells 0.085 0.085-0.6 1 3 [22b] 
Amperometric ADI 0.001 0.003 – 0.2 0.25  Over 35 
Presented in 
the current 
paper 
* ASE – ammonium-selective electrode; **U/A – Urease and arginase I. 
 
In our study “Aminoplazmal 10% E”, an L-Arg-containing pharmaceutical was tested as it 
represents one of the most interesting L-Arg-containing commercially available samples 
(according to the manufacturer's certificate, this pharmaceutical contains a number of amino acids 
and other additives). The results of L-Arg assay in the “Aminoplazmal 10% E” using the biosensor 
were compared with those declared by manufacturer and only slight differences were observed 
(RSD is less than 2.5% for n = 3) (Fig. 3). 
 
Table 2: Analytical performance of the L-Arg biosensor for real samples. 
Sample 
L-Arg + NH4+, 
mM 
NH4+, 
mM 
L-Arg calculated, 
mM 
L-Arg reference 
assay, 
mM 
Measured by 
biosensor 
Measured by 
PANi/Nafion/Pt-
SPE 
 Fluorometric detection 
Pharmaceutical 7.8±0.3 - 7.8±0.3 8.0** 
Plasma 1 0.157±0.022 0.07±0.01 0.087±0.014 0.082±0.008*** 
Plasma 2 0.127±0.018 0.047±0.006 0.079±0.012 0.071±0.007*** 
Plasma 3* 0.392±0.051 0.23±0.02 0.162±0.021 0.144±0.015*** 
Plasma 4* 0.445±0.063 0.25±0.03 0.195±0.027 0.179±0.018*** 
*  Collected from patients with hepatic disorder 
**  Declared by producer 
***  Fluorometric detection  
 The L-Arg biosensor was also tested for the L-
Arg quantification in plasma samples of healthy donors 
and patients with hepatic disorder using the standard 
addition method (RSD – 14% for n = 3). Due to the fact 
that in serum/plasma of healthy humans the 
concentrations of L-Arg and endogenous ammonium 
ions are very close (60-100 µM [32] and 20-50 µM [34], 
respectively), the latter was additionally measured in 
plasma samples with the PANi/Nafion/Pt-SPE. A 
concentration of L-Arg in plasma was calculated as a 
difference between the signals of ADI/PANi/Nafion/Pt-
SPE- and PANi/Nafion/Pt-SPE -based sensors. 
 
Figure 3. L-Arg analyses in pharmaceutical “Aminoplazmal 
10% E” by ADI sensor using method of standard additions. A: 
an example of amperometric response of L-Arg sensor to 
2000-fold dissolved “Aminoplazmal” sample and subsequent 
standard additions (#1, #2, #3) of L-Arg (-0.35 V, PB pH 7.4); 
B: calibration curves for L-Arg detection in “Aminoplazmal” 
sample dissolved 2000-fold (n=3). Statistical data: parameters 
of linear regression; R2 – linear regression coefficient; n – dilution factor; Ccalcul. – calculated 
ammonia/arginine concentration in plasma sample. 
 
The data presented showed a strong correlation with the reference method for L-Arg 
measurement based on fluorometry with an RSD of 10%. The L-Arg concentration in plasma of 
healthy donors was 1.5-2 times lower than in plasma of patients with hepatic disorder. The results 
of L-Arg assays, presented in Table 2, are close to previously reported values for healthy adults 
[4, 32] and patients with hepatic disorder [35]. These results indicate that the L-Arg biosensor 
presented here can be exploited for fast and effective assay of L-Arg in simple (pharmaceuticals) 
and complex (human plasma) media. 
 
4. Conclusions 
 
An amperometric L-Arg biosensor based on recombinant ADI has been developed and 
optimised for the first time. The biosensor is characterised by a low applied potential (-0.35 V), 
fast response time (15 s), broad linear range (0.003 to 0.2 mM), high selectivity and sensitivity 
(684±32 A⋅M-1⋅m-2), a low limit of detection (0.001 mM) and good storage stability (>35 days). 
The L-Arg amperometric biosensor facilitated facile analysis of real samples; there was no need 
for complex sample pretreatment (except sample dilution) due to the one-step L-Arg 
transformation by arginine deiminase. This performance cannot be achieved for bi-enzyme 
(arginase and urease) and for mono-enzyme (inhibitory urease) sensor formats reported previously 
as they will always suffer from the necessity to eliminate the endogenous urea in plasma, blood 
and urine samples). Measurements in real samples (pharmaceutical and human plasma) proved to 
be in a good agreement with reference fluorometric enzymatic assay (RSD do not exceed 10%).   
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 Graphical abstract. An amperometric biosensor for sensitive and selective detection of L-Arginine 
based on a Nafion/polyaniline (PANi) composite at a platinum screen-printed electrode (Pt-SPE) using a novel 
recombinant arginine deiminase (ADI) from Mycoplasma hominis is reported. 
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Figure 1S. Schematic representation of the biosensor. PANi+ and PANi0—oxidised and 
reduced forms of PANi, respectively; RSO3− - Nafion. (Stasyuk et al. 2012) 
  
 
Fig. 2S. Electrochemical polymerisation of PANi onto Nafion-modified PSPE (0.5 M HCl, 
0.2 M aniline, scan rate 0.02 V/s vs Ag/AgCl). 
 
  
-500
-400
-300
-200
-100
0
100
200
300
-0.6 -0.4 -0.2 0 0.2 0.4 0.6 0.8 1 1.2
I /
 µ
A
E / V
1-7
cycles
 
Fig. 3S. Selection of the optimal potential for ammonium ion amperometric detection 
(20 mM PB pH 7.4, vs Ag/AgCl). 
 
 
Fig. 4S. Selection of the optimal pH for L-Arg amperometric detection 
(-0.35 V vs Ag/AgCl in 20 mM PB, at 22 °C). 
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Fig. 5S. Effects of some possible interfering compounds on the L-Arg biosensor. 
Measurement conditions: −0.35 V vs Ag/AgCl in 20 mM PB pH 7.4. 
0.1 mM L-Arg, 0.2 mM Ile, Lys, Thr, Orn, Ser, Val, Cys, GABA and citrulline. 
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Fig. 6S. Stability of the L-Arg biosensor. Response of ADI/PANi/Nafion/PSPE to 0.2 mM L-
Arg. Storage conditions: 50 mM PB pH 7.4 at + 4 ºC. Measurement conditions: -0.35 V vs Ag/AgCl in 
20 mM PB pH 7.4. 
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 Fig. 7S. Influence of sodium chloride on the L-Arginine biosensor response (-0.35 V vs 
Ag/AgCl in 20 mM PB pH 7.4.) 
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